Literature DB >> 11141236

Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.

S Kubo1, S Nishiguchi, H Hamba, K Hirohashi, H Tanaka, T Shuto, H Kinoshita, T Kuroki.   

Abstract

OBJECTIVE: To investigate the mechanisms and risk factors underlying postoperative reactivation of hepatitis after liver resection for hepatitis B virus-related hepatocellular carcinoma. SUMMARY BACKGROUND DATA: Although risk factors for acute hepatic failure after liver resection have been reported in patients with chronic liver disease, the issue of reactivation of hepatitis B virus replication after liver resection is unresolved.
METHODS: Fifty-five patients with hepatocellular carcinoma and hepatitis B surface antigen underwent liver resection. In 25 of these 55 patients, serum levels of hepatitis B virus DNA and the type of hepatitis B virus were determined before and after surgery.
RESULTS: Postoperative hepatitis occurred in 13 of the 55 patients (24%). Reactivation of viral replication occurred after liver resection in 7 of the 25 patients tested, and alanine aminotransferase activity increased in 6 of these 7 patients. High preoperative alanine aminotransferase activity, high levels of hepatitis B virus DNA, presence of wild-type DNA, and detection of hepatitis B core antigen in hepatocytes, all features of the immune clearance phase in the natural course of hepatitis B virus infection with no surgery, were more likely to be found in patients with reactivation than in patients without reactivation.
CONCLUSIONS: During the immune clearance phase of hepatitis B virus infection, especially the period of acute exacerbation, changes in serum hepatitis B virus DNA level should be monitored for early warnings of reactivation of viral replication, likely to cause severe postoperative hepatitis and acute hepatic failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141236      PMCID: PMC1421176          DOI: 10.1097/00000658-200101000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  41 in total

1.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.

Authors:  M Omata; T Ehata; O Yokosuka; K Hosoda; M Ohto
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

Review 3.  Classification of chronic hepatitis: diagnosis, grading and staging.

Authors:  V J Desmet; M Gerber; J H Hoofnagle; M Manns; P J Scheuer
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

4.  Estimation of risk of major complications after hepatic resection.

Authors:  M Shimada; T Matsumata; K Akazawa; T Kamakura; H Itasaka; K Sugimachi; Y Nose
Journal:  Am J Surg       Date:  1994-04       Impact factor: 2.565

5.  Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.

Authors:  P W Angus; S A Locarnini; G W McCaughan; R M Jones; J S McMillan; D S Bowden
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

6.  Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States.

Authors:  T Laskus; D H Persing; M J Nowicki; J W Mosley; J Rakela
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

7.  Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay.

Authors:  M R Brunetto; A Randone; M Ranki; A Jalanko; P Piantino; M Giarin; G Capra; P L Calvo; F Oliveri; F Bonino
Journal:  J Med Virol       Date:  1994-07       Impact factor: 2.327

8.  GB virus C infection by blood transfusion during and following liver surgery.

Authors:  S Kubo; S Nishiguchi; K Hirohashi; H Tanaka; T Shuto; H Kinoshita; T Kuroki
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

9.  Precore mutant hepatitis B virus infection and liver disease.

Authors:  N V Naoumov; R Schneider; T Grötzinger; M C Jung; S Miska; G R Pape; H Will
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

10.  Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis.

Authors:  W F Carman; E A Fagan; S Hadziyannis; P Karayiannis; N C Tassopoulos; R Williams; H C Thomas
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

View more
  18 in total

1.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

2.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

Review 3.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

4.  2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 5.  Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system.

Authors:  Masayuki Ishii; Toru Mizuguchi; Kohei Harada; Shigenori Ota; Makoto Meguro; Tomomi Ueki; Toshihiko Nishidate; Kenji Okita; Koichi Hirata
Journal:  World J Hepatol       Date:  2014-10-27

6.  Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B.

Authors:  Sang Myung Woo; Joong-Won Park; Woo Jin Lee; Chang-Min Kim
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

Review 7.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

8.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

Review 9.  Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Akinori Nozawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Yorihisa Urata
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 10.  Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.

Authors:  Jeong Won Jang
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.